Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

27480-30-4Clindamycin Phosphate EP Impurity F

● In Stock

Catalogue No.:	VL1030010
CAS No.:	27480-30-4
Mol. Formula:	C18H35N2O9PS
Mol. Weight:	486.52 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 27480-30-4

Parent drug

Clindamycin

IUPAC Name

Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-2-O-phosphono-1-thio-D-erythro-Î±-D-galacto-octopyranoside

Pharmacopoeial Synonyms

Lincomycin 2-phosphate

Other Synonyms

N/A

Smiles

CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@@H](C)O

InChI

InChI=1S/C18H35N2O9PS/c1-5-6-10-7-11(20(3)8-10)17(24)19-12(9(2)21)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,21-23H,5-8H2,1-4H3,(H,19,24)(H2,25,26,27)/t9-,10-,11+,12-,13-,14+,15-,16-,18-/m1/s1

Description

Clindamycin Phosphate EP Impurity F also known as Lincomycin 2-phosphate ,in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Clindamycin.